In vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PET
Objective(s): The ability to measure cellular proliferation non-invasively in renal cell carcinoma may allow prediction of tumour aggressiveness and response to therapy. The aim of this study was to evaluate the uptake of 18Ffluorothymidine (FLT) PET in renal cell carcinoma (RCC), and to compare thi...
Main Authors: | Peter K. Wong, Sze Ting Lee, Carmel Murone, John Eng, Nathan Lawrentschuk, Salvatore U. Berlangieri, Kunthi Pathmaraj, Graeme J. O'Keefe, John Sachinidis, Amanda J. Byrne, Damien M. Bolton, Ian D. Davis, Andrew M. Scott |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2014-05-01
|
Series: | Asia Oceania Journal of Nuclear Medicine and Biology |
Subjects: | |
Online Access: | http://aojnmb.mums.ac.ir/pdf_2283_96578354274e1094025c50346211de20.html |
Similar Items
-
18F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study
by: Perrin E. Romine, et al.
Published: (2021-08-01) -
FLT-PET for the assessment of systemic sarcoidosis including cardiac and CNS involvement: a prospective study with comparison to FDG-PET
by: Patrick Martineau, et al.
Published: (2020-12-01) -
Molecular Imaging with 3′-deoxy-3′[(18)F]-Fluorothymidine (<sup>18</sup>F-FLT) PET/CT for Early Response to Targeted Therapies in Sarcomas: A Pilot Study
by: Kalevi Kairemo, et al.
Published: (2020-02-01) -
Pilot study assessing 18F-fluorothymidine PET/CT in cervical and vaginal cancers before and after external beam radiation
by: Linda P. Cho, et al.
Published: (2015-11-01) -
FDG-PET AND PET/CT - Part I
by: Amol M Takalkar, et al.
Published: (2007-07-01)